Improving Access to Influenza Testing and Treatment: Is It Time for Over-the-counter Oseltamivir? - Top-Institutions - MDSpire

Improving Access to Influenza Testing and Treatment: Is It Time for Over-the-counter Oseltamivir?

  • By

  • Kyueun Lee

  • Andrew T Pavia

  • Janet A Englund

  • October 17, 2025

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Centers for Disease Control and Prevention (CDC)
    Centers for Disease Control and Prevention (CDC)

    Atlanta, GA

    Key Differentiators

    • Infectious Diseases
    • Epidemiology
    • Public Health

  • #2

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Infectious Diseases
    • Clinical Pharmacology
    • Epidemiology

  • #3

    University of Washington School of Medicine
    University of Washington School of Medicine

    Seattle, WA

    Key Differentiators

    • Infectious Diseases
    • Virology
    • Pharmacology

  • #4

    Massachusetts General Hospital / Harvard Medical School
    Massachusetts General Hospital / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Infectious Diseases
    • Clinical Research
    • Public Health

  • #5

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Infectious Diseases
    • Pharmacology
    • Epidemiology

Original Source(s)

Improving Access to Influenza Testing and Treatment: Is It Time for Over-the-counter Oseltamivir?

  • by Kyueun Lee, Andrew T Pavia, Janet A Englund

  • October 17, 2025

Related Content

SARS-CoV-2 in Pregnancy—More Hints of Rare Complications

RSV Vaccine Eligibility Expands

Trial data show noninferior immune response in high-risk adults aged 18 to 49 years.

Research progress in the inhibitory mechanisms of traditional Chinese medicine therapies against influenza A